A Review of Japanese Encephalitis Vaccines with Respect to Potential Veterinary Use.

IF 1.8 4区 医学 Q3 INFECTIOUS DISEASES
Vector borne and zoonotic diseases Pub Date : 2026-07-01 Epub Date: 2026-03-25 DOI:10.1177/15303667261434503
Audrey Matheny, Susan M Hettenbach, Ashlie M Ake, Stephen Higgs, Dana L Vanlandingham
{"title":"A Review of Japanese Encephalitis Vaccines with Respect to Potential Veterinary Use.","authors":"Audrey Matheny, Susan M Hettenbach, Ashlie M Ake, Stephen Higgs, Dana L Vanlandingham","doi":"10.1177/15303667261434503","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Japanese encephalitis virus (JEV) is a reemerging vector-borne orthoflavivirus of significant public and animal health concern. Infection with JEV can cause inapparent, mild, or fatal encephalitis in humans and animals. The virus, which circulates primarily in Southeast Asia, has caused outbreaks in humans and livestock in nonendemic regions, leading to human disease and significant economic loss. The 2022 Australian outbreak of JEV led to renewed interest in JEV countermeasures available in the United States for veterinary use as the Australia outbreak primarily affected commercial swine farms. There are currently no antivirals or veterinary vaccines available to protect animals from JEV infection, and only one vaccine is approved for human use in the United States. In the event of a JEV introduction to the United States, vaccination of susceptible reservoirs, like domestic swine, may help prevent economic loss and JEV from establishing endemicity in the United States.</p><p><strong>Methods: </strong>This review assesses recent advances in JEV vaccine development with an interest in veterinary applications. This systematic review was conducted by searching databases (PubMed, Web of Science, Scopus, and EBSCOhost).</p><p><strong>Results: </strong>Eighty-seven research articles focused on the evaluation of novel JEV vaccine candidates were included in this review.</p><p><strong>Conclusion: </strong>Although there are a variety of different methodologies being employed in the development of JEV vaccine candidates, including recombinant live virus vaccines utilizing insect-only flaviviruses as vectors for JEV antigens and virus-like particle vaccines using various JEV genes to elicit protection among different JEV genotypes. While there are many promising candidates being developed, most are likely several years away from commercial production and would not be available if JEV were introduced to the United States within the next several years. Therefore, other disease control strategies should be investigated.</p>","PeriodicalId":23683,"journal":{"name":"Vector borne and zoonotic diseases","volume":" ","pages":"377-388"},"PeriodicalIF":1.8000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vector borne and zoonotic diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15303667261434503","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Japanese encephalitis virus (JEV) is a reemerging vector-borne orthoflavivirus of significant public and animal health concern. Infection with JEV can cause inapparent, mild, or fatal encephalitis in humans and animals. The virus, which circulates primarily in Southeast Asia, has caused outbreaks in humans and livestock in nonendemic regions, leading to human disease and significant economic loss. The 2022 Australian outbreak of JEV led to renewed interest in JEV countermeasures available in the United States for veterinary use as the Australia outbreak primarily affected commercial swine farms. There are currently no antivirals or veterinary vaccines available to protect animals from JEV infection, and only one vaccine is approved for human use in the United States. In the event of a JEV introduction to the United States, vaccination of susceptible reservoirs, like domestic swine, may help prevent economic loss and JEV from establishing endemicity in the United States.

Methods: This review assesses recent advances in JEV vaccine development with an interest in veterinary applications. This systematic review was conducted by searching databases (PubMed, Web of Science, Scopus, and EBSCOhost).

Results: Eighty-seven research articles focused on the evaluation of novel JEV vaccine candidates were included in this review.

Conclusion: Although there are a variety of different methodologies being employed in the development of JEV vaccine candidates, including recombinant live virus vaccines utilizing insect-only flaviviruses as vectors for JEV antigens and virus-like particle vaccines using various JEV genes to elicit protection among different JEV genotypes. While there are many promising candidates being developed, most are likely several years away from commercial production and would not be available if JEV were introduced to the United States within the next several years. Therefore, other disease control strategies should be investigated.

日本脑炎疫苗的潜在兽医应用综述。
背景:日本脑炎病毒(JEV)是一种重新出现的媒介传播的正黄病毒,对公众和动物健康具有重要意义。乙型脑炎病毒感染可在人和动物中引起不明显、轻度或致命的脑炎。该病毒主要在东南亚传播,已在非流行地区的人类和牲畜中造成疫情,导致人类患病和重大经济损失。由于澳大利亚的疫情主要影响商业养猪场,2022年澳大利亚爆发的乙脑病毒引起了人们对美国用于兽医的乙脑病毒对策的重新关注。目前没有抗病毒药物或兽医疫苗可用于保护动物免受乙脑病毒感染,而且在美国只有一种疫苗被批准用于人类。如果将乙脑病毒引入美国,对易感宿主(如家猪)接种疫苗可能有助于防止经济损失和乙脑病毒在美国形成地方性流行。方法:本文综述了乙脑疫苗在兽医应用方面的最新进展。本系统综述通过检索数据库(PubMed、Web of Science、Scopus和EBSCOhost)进行。结果:本综述纳入了87篇关于新型乙脑候选疫苗评价的研究论文。结论:目前在乙脑候选疫苗的开发中采用了多种不同的方法,包括利用纯昆虫黄病毒作为乙脑抗原载体的重组活病毒疫苗,以及利用多种乙脑基因在不同的乙脑基因型中引起保护作用的病毒样颗粒疫苗。虽然有许多有希望的候选疫苗正在开发中,但大多数可能还需要几年时间才能实现商业化生产,如果在未来几年内将乙脑病毒引入美国,则无法获得。因此,应研究其他疾病控制策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.70
自引率
4.80%
发文量
73
审稿时长
3-8 weeks
期刊介绍: Vector-Borne and Zoonotic Diseases is an authoritative, peer-reviewed journal providing basic and applied research on diseases transmitted to humans by invertebrate vectors or non-human vertebrates. The Journal examines geographic, seasonal, and other risk factors that influence the transmission, diagnosis, management, and prevention of this group of infectious diseases, and identifies global trends that have the potential to result in major epidemics. Vector-Borne and Zoonotic Diseases coverage includes: -Ecology -Entomology -Epidemiology -Infectious diseases -Microbiology -Parasitology -Pathology -Public health -Tropical medicine -Wildlife biology -Bacterial, rickettsial, viral, and parasitic zoonoses
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书